Video White Paper: The Applications Of Positron Emission Tomography (PET) In New Drug Development

By Barry Siegel, MD, Medical Director, ACR Image Metrix

Positron Emission Tomography (PET) is widely recognized as the paradigm of molecular imaging. Its strengths as an imaging method include high photon detection efficiency and high spatial resolution, by comparison with conventional radio-nuclide imaging methods. It also has high quantitative accuracy and a wide variety of radiopharmaceuticals that can be used to interrogate regional physiology or patho-physiology.

Over the last decade, PET has emerged from its previously limited role as a research tool into a widely-used clinical method, most notably for imaging of cancer, as well as for various neurologic disorders.